Abstract
Paraneoplastic pemphigus is a rare but severe potentially fatal autoimmune disease characterized by severe stomatitis and a variety of cutaneous manifestations in association with an underlying neoplasia. Pulmonary involvement may also occur. The pathogenesis involves the production of autoantibodies against desmogleins, plakins and the protease inhibitor alpha-2 macroglobuline like-1, but T-cell mediated autoimmunity is also thought to play a role. Diagnosis usually relies on the demonstration of a specific subset of circulating autoantibodies in patient serum, although in a small subset of patients these autoantibodies might be absent. Due to it's rarity, there are no guidelines for the treatment of PNP. The general approach includes a variety of immunosuppressive agents and treatment of the underlying neoplasia. Despite treatment, paraneoplastic pemphigus has high mortality rates, often due to sepsis, respiratory failure or progression of the underlying malignancy.
| Original language | English |
|---|---|
| Title of host publication | Autoimmune Bullous Diseases |
| Subtitle of host publication | Text and Review |
| Publisher | Springer International Publishing AG |
| Pages | 87-91 |
| Number of pages | 5 |
| ISBN (Electronic) | 9783030915575 |
| ISBN (Print) | 9783030915568 |
| DOIs | |
| Publication status | Published - 19-Jan-2022 |
Keywords
- Alpha-2-macroglobulin-like-1
- Autoimmune disease
- Neoplasia
- Paraneoplastic
- Paraneoplastic autoimmune multiorgan syndrome
- Pemphigus
- Plakins
- Stomatitis